Literature DB >> 7201844

Effects of prostaglandin E1 and other vasodilator agents in pulmonary hypertension of scleroderma.

M Baron, G Skrinskas, R Hyland, M B Urowitz.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7201844      PMCID: PMC481250          DOI: 10.1136/hrt.48.3.304

Source DB:  PubMed          Journal:  Br Heart J        ISSN: 0007-0769


× No keyword cloud information.
  6 in total

1.  Observations on the effects of infusion of prostaglandin E in man.

Authors:  S BERGSTROM; H DUNER; U von EULER; B PERNOW; J SJOVALL
Journal:  Acta Physiol Scand       Date:  1959-03-31

2.  Prostacyclin and prostaglandin E1 for severe idiopathic pulmonary artery hypertension.

Authors:  W D Watkins; M B Peterson; R K Crone; D C Shannon; L Levine
Journal:  Lancet       Date:  1980-05-17       Impact factor: 79.321

3.  Prostacyclin for pulmonary hypertension.

Authors:  J Szczeklik; A Szczeklik; R Nizankowski
Journal:  Lancet       Date:  1980-11-15       Impact factor: 79.321

4.  Intravenous prostaglandin E1 in severe peripheral vascular disease.

Authors:  L A Carlson; A G Olsson
Journal:  Lancet       Date:  1976-10-09       Impact factor: 79.321

5.  Effects of prostaglandin E1 on pulmonary circulation in patients with pulmonary hypertension.

Authors:  J Szczeklik; J S Dubiel; M Mysik; Z Pyzik; R Krol; T Horzela
Journal:  Br Heart J       Date:  1978-12

6.  Haemodynamic effects of prostacyclin (PGI2) in pulmonary hypertension.

Authors:  D N Guadagni; H Ikram; A H Maslowski
Journal:  Br Heart J       Date:  1981-04
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.